Holen Sie sich die Stockscreener-App
14.63
4.81%
-0.74
Handel nachbörslich:
14.86
0.23
+1.57%
Schlusskurs vom Vortag:
$15.37
Offen:
$15.17
24-Stunden-Volumen:
3.67M
Relative Volume:
1.08
Marktkapitalisierung:
$3.49B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
17.23
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
-6.04%
1M Leistung:
-0.20%
6M Leistung:
-37.80%
1J Leistung:
-23.44%
1-Tages-Spanne:
$14.62
$15.58
1-Wochen-Bereich:
$14.62
$15.76
52-Wochen-Spanne:
$13.82
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
14.63 | 3.67B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Biologics Inc (ADMA) Q3 2025: Everything You Need to Know A - GuruFocus
Risk adjusted return profile for ADMA Biologics Inc. analyzed2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Can ADMA Biologics Inc. stock attract ESG capital inflowsRate Hike & Risk Managed Investment Entry Signals - newser.com
Will ADMA Biologics Inc. stock keep outperforming rivalsDollar Strength & Stepwise Entry and Exit Trade Signals - newser.com
Y Intercept Hong Kong Ltd Buys 38,809 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Applying Wyckoff theory to ADMA Biologics Inc. stockJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
ADMA Biologics (ADMA): Evaluating Valuation After Major Institutional Exit by Palisades Investment Partners - Yahoo Finance
Building trade automation scripts for ADMA Biologics Inc.Market Movers & Verified Technical Signals - newser.com
ADMA Biologics (ADMA) to Release Quarterly Earnings on Thursday - MarketBeat
ADMA Biologics Inc Stock Analysis and ForecastSector Performance Drivers & Free Take Advantage Of Momentum - earlytimes.in
Will ADMA Biologics Inc. stock continue dividend increasesTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
ADMA Biologics, Inc. (ADMA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
ADMA Biologics Inc (ADMA) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - sharewise.com
ADMA Biologics Inc (ADMA) Stock forecasts - Yahoo! Finance UK
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
ADMA Biologics (Nasdaq: ADMA) sets Nov. 5 call at 4:30 p.m. ET for third-quarter results - Stock Titan
Is ADMA Biologics Stock Trading At A Bargain? - Trefis
Signal Recap: Why ADMA Biologics Inc. stock is a must watch in 2025Earnings Performance Report & Verified Swing Trading Watchlist - fcp.pa.gov.br
Peregrine Capital Management LLC Acquires 53,515 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Will ADMA Biologics Inc. stock outperform international peersExit Point & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br
Risk Check: Why ADMA Biologics Inc. stock is a must watch in 2025 - Fundação Cultural do Pará
Analyst Upgrade: Will ADMA Biologics Inc. stock continue dividend increasesPortfolio Value Summary & Real-Time Volume Spike Alerts - fcp.pa.gov.br
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - sharewise.com
ADMA Biologics Adjusts Valuation Amid Strong Financial Performance and Growth Metrics - Markets Mojo
Is ADMA Biologics Inc a good long term investmentEarnings Date Calendar & Low Entry Investment Ideas - earlytimes.in
ADMA Biologics (ADMA): Assessing Valuation After Q2 Earnings Miss and Upgraded Financial Outlook - Sahm
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):